Nabumetone Tablet
Product Images NDC 85766-261

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Nabumetone (NDC 85766-261). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sportpharm Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure1 (Figure1)

A line graph showing Nabumetone active metabolite (6MNA) plasma concentrations over time at steady state following once-daily dosing of 1000 mg (n=31) and 2000 mg (n=12). The y-axis is labeled concentration (ng/mL) and the x-axis is time in hours. Shaded bands represent ±2 standard deviations for each dose group.*

FDA Label Image

500 (Label 500mg)

Sheet of multiple Nabumetone Tablets, USP 500 mg packaging labels repackaged or relabeled for Sportpharm LLC. Labels display the product name, strength 500 mg, dosage form tablet, various quantities ranging from 6 to 100 tablets, NDC numbers, and manufacturer SciGen Pharmaceuticals, Inc. Each label includes a barcode, QR code, drug status RX, batch and lot placeholders, and storage instructions.*

FDA Label Image

750 (Label 750mg)

Labels for Nabumetone Tablets, USP 750 mg, repackaged or relabeled for Sportpharm LLC. Each label displays the product name, strength (750 mg), NDC codes, quantities ranging from 6 to 100 tablets, and manufacturer SciGen Pharmaceuticals, Inc. The labels include packaging information such as drug status (RX), description of tablets (white, oval, biconvex film-coated debossed), batch and lot placeholders, and a QR code on each.*

FDA Label Image

Structure1 (Structure1)

Chemical structure diagram of Nabumetone, showing its molecular formula C15H16O2 and molecular weight 228.3.*

FDA Label Image

Structure2 (Structure2)

Chemical structure of 6-methoxy-2-naphthylacetic acid (6MNA), the active metabolite of nabumetone, shown with labeled functional groups and a naphthalene ring system.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.